• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Serious No More High SES Cancer Treatment for Sinkies to Make Medisave Substainable! Sick Sinkies Better Died Then Waste Everyone's Time!

Pinkieslut

Alfrescian
Loyal

MOH to provide additional support for cancer patients affected by changes to treatment claim policies​

Cancer drug spending grew 20 per cent per year from 2016 to 2019, said MOH, adding that this was not sustainable.
TODAY file photo
Cancer drug spending grew 20 per cent per year from 2016 to 2019, said MOH, adding that this was "not sustainable".
Follow us on Instagram and Tiktok, and join our Telegram channel for the latest updates.
Published September 2, 2022
Updated September 2, 2022
WhatsAppTelegramFacebookTwitterEmailLinkedIn
SINGAPORE — The Ministry of Health (MOH) announced on Friday (Sept 2) additional transitional support for cancer patients who are affected by changes to treatment claim policies that took effect on Thursday.
In August last year, MOH announced changes to the MediShield Life, MediSave and Integrated Shield Plan (IP) coverage, as well as established a Cancer Drug List (CDL).


Under the changes, which took effect on Thursday, only treatments that are listed on the CDL are covered under MediShield Life and MediSave. IP coverage will also be adjusted from April 1, 2023, upon policy purchase or renewal.
Cancer drug spending grew 20 per cent per year from 2016 to 2019, said MOH, adding that this was "not sustainable". The changes were made to address this issue.
MOH has also extended drug subsidies through the Medication Assistance Fund to more Singapore residents at public healthcare institutions. This will help improve the affordability of clinically and cost-effective cancer drugs, it said.

READ ALSO​

Cancer treatment to be more affordable under changes to Medishield Life and other schemes: MOH


Currently, more than 90 per cent of cancer treatments approved by the Health Sciences Authority are on the CDL. This will continue to expand as the ministry continues to engage drug companies and as new clinical evidence emerges.

SUPPORT DURING TRANSITION PERIOD​

Patients in public and private healthcare institutions who started treatments that are not on the CDL, or are on the CDL but not subsidised before Sept 1, may find themselves affected by the policy change, said MOH.


Out-of-pocket expenses may go up, until the drugs are included or subsidised on the CDL.
"We will provide additional support for this group of patients during this transition period so that their ongoing course of treatment is not disrupted," said MOH.
Patients with IPs that currently cover their treatments will not see any change to their coverage from Sept 1, as the changes to IPs will only kick in on their policy renewal date from April 1 next year.
Additionally, all IP insurers have committed to providing support during this transitional period to policyholders undergoing cancer drug treatments beyond April 1, 2023.


Patients with MediShield Life only will receive additional financial support for their current course of treatment.


"Generally, they will not need to pay more cash as compared to before," said MOH, adding that patients may approach their respective public healthcare institutions for more details.
Those who are receiving private care and need further financial assistance may also request to be directly referred to subsidised specialist care at public healthcare institutions, where their treatment plan will be reviewed and they can apply for additional financial support.
At a dinner hosted by the Singapore Cancer Society on Friday, Health Minister Ong Ye Kung said he hoped that with the changes, effective cancer treatments can be made more accessible and affordable to all future patients.
"But there will be mid-flight patients, meaning those who are in the middle of their treatment, using cancer drugs not on the CDL," he said.
"So we should avoid the situation where they will find the cost of their cancer drugs shoot up suddenly. We should make provisions, so that the impact on them should be minimal, if not zero."


The additional support for these patients will allow them to complete their treatment with minimal or no impact to their out-of-pocket expenses after MediSave withdrawals and MediShield Life claims, said Mr Ong.
If these patients have IPs, insurers have committed to continue their current IP coverage at least until September next year, he added.
The Life Insurance Association announced on Friday that all seven insurers offering IP will provide additional support for policyholders amid the implementation of the CDL.
They will keep premium rates for IPs steady from Friday to Aug 31, 2024, although this will not apply to IP riders.
The insurers will also provide transitional support until Sept 30, 2023, for patients whose IPs are renewing between April 1, 2023 and Sept 30, 2023, and are actively undergoing cancer drug treatments as of March 31, 2023.
"This transitional support will provide affected IP policyholders more time to deliberate on their treatment plans and adjust to the change by switching to suitable alternatives on the CDL, where appropriate," said the Life Insurance Association.
"It is critical that treatment decisions are made only upon adequate consultation and discussions with doctors on the way forward. Policyholders are also encouraged to engage their IP insurers to seek clarifications, if required, before commencing treatments."
Future patients, together with their oncologists, should consider treatment options on the CDL, which are "clinically proven and more cost effective", before considering alternatives, said MOH.
"Notwithstanding, IP insurers have decided that their riders’ coverage will continue to cover treatments beyond the CDL," said MOH, adding that this will provide greater choice for those who prefer and wish to pay for broader coverage. CNA
 

laksaboy

Alfrescian (Inf)
Asset
Slowly but surely, euthanasia will be legalized. No need to elaborate, you can connect the dots from the stuff published on the mouthpiece media.
 

eatshitndie

Alfrescian (Inf)
Asset
Slowly but surely, euthanasia will be legalized. No need to elaborate, you can connect the dots from the stuff published on the mouthpiece media.
euthanasia is an enlightened concept practised by advanced sentient beings in the universe. so said edgar cayce as he wrote that earthlings in the far future will surround their great grannies while they’re still alive and watch them take the white pill with a glass of water to move on to the next life.
 

Leongsam

High Order Twit / Low SES subject
Admin
Asset

Dying a good death: what we need from drugs that are meant to end life


Published: October 20, 2017 1.24pm NZDT


Generally speaking, health care is aimed at relieving pain and suffering. This is also the motivation behind euthanasia – the ending of one’s own life, usually in the case of terminal illness characterised by excruciating pain.
There has been debate in Victoria about the drugs that should be used to end life if euthanasia is legalised. So which medications can we ensure would facilitate the best, medically-supervised death?

Medicine as poison​

When it comes to the question of which medicines can, or even are meant to, kill us, the most important thing to remember is the old adage:

The dose makes the poison.

Get news that’s free, independent and based on evidence.​


This concept is one on which the whole discipline of toxicology and medicines is founded. This is the meaning of the well-known symbol of the snake, wound around the bowl of Hygeia (the Greek goddess of health), representing medicine, which you see in pharmacies and medical centres around the world. The intertwining of poison and health care is a longstanding concept in the therapeutic use of medicines.




Medicine is poison - depending on the dose.

This is a very intricate science, and the reason we conduct clinical research. We need to trial different doses of new drugs to meticulously establish a safe but effective threshold for use.


In more practical terms, this means too much of any medicine can cause harm. Take, for example, the humble paracetamol. When taken following correct guidelines, it is a perfectly safe, effective pain killer used by millions of people worldwide. But taken in excessive quantities, it can cause irreparable liver damage, and if the patient is not given an antidote in a hospital, could lead to death.




Read more: Ruling on assisted dying drug Nembutal sets important precedent




What drugs are used in assisted dying?​


The group of drugs most commonly used to end life is called the barbiturates. They cause the activity of the brain and nervous system to slow down. These drugs, used medicinally in small doses, can be taken short-term to treat insomnia, or seizures in emergencies. In different doses and administration techniques, these preparations can also be used as anaesthesia, to make us sleep through surgery.


An overdose of barbiturates is fatal. A large dose will effectively make the brain slow down to a point where it stops telling the body to keep the respiratory system working, and breathing ceases.


Both secobarbital capsules and pentobarbital (usually known as the brand name, Nembutal) liquid - (not to be mistaken for epilepsy medication phenobarbital) have been used either alone or in combination for physician-assisted suicide or euthanasia. They are also used in injectable forms for animal euthanasia.


These two products are tried and tested, have the advantage of years of use with the benefit of knowing the exact dose range needed, and with few adverse effects reported (such as unexpected pain, drawn-out death or failed death).


Their safety and efficacy in inducing a peaceful, swift and uneventful death has been proven around the world. They are the preferred drugs in the Netherlands, Belgium, Switzerland and some USA states where euthanasia is legal.


Other options exist, whether in combination or alone, but have limited evidence of use in euthanasia. Some drugs that cause excessive muscle relaxation and respiratory distress can end life, as can some pain killers commonly used in palliative care.


Drugs can also be used that fatally lower blood sugar levels, cause heart attack, or block messages from the brain to the muscles, causing paralysis.


While all of these drugs are legally available in Australia, they could cause a long, protracted death, with many more side effects that could cause distress and suffering at the end of life. Nembutal and its relatives are less likely to do so, with greater evidence from international practices than any other drugs that can end life.


The ‘best’ death​


In Australia, Nembutal and secobarbital can be used for animals, but are illegal for human use. This makes implementation of the newly proposed euthanasia law in Victoria slightly more difficult. The proposed legislation does not seek to legalise the use of Nembutal and its relatives - but suggests a “drug cocktail” be concocted by a compounding pharmacist.


The Victorian government has reportedly approached Monash University’s pharmacy department to research the kind of pill that could be developed if the legislation passes. Therefore, no final description of this product has been released.


Some have suggested the mixture will be in powder form made with pain killers to induce a coma and eventually cause respiratory arrest. It may also use sedatives and muscle relaxants, a drug to slow down the heart, and an anti-epileptic to prevent seizure and induce relaxation of muscles. The constituents and doses are yet to be determined.


It’s difficult at this early stage to predict how this concoction would work and whether it would be easier or safer to use than drugs already tried and tested. This proposed product would need to be tested and results compared, as all new drugs are.


What is needed is a drug or a mixture of drugs that produce a painless, relatively quick and peaceful passing. We do not wish to see further suffering in the form of seizures, prolonged distress and pain. If no solution is certain, it would be wise to fall back on simply legalising what is already tried and tested.




If you or someone you know needs help contact Lifeline’s 24-hour helpline on 13 11 14, SANE Australia on 1800 18 7263 or the Beyondblue Info Line 1300 22 4636.

 

k1976

Alfrescian
Loyal
Slowly but surely, euthanasia will be legalized. No need to elaborate, you can connect the dots from the stuff published on the mouthpiece media.
Like that, Bedok will be made a "retirement" village for those who want to "quiet quit" this world?
 
Top